HRQoL in patients with WM treated with BTKis

Poster presented at EHA2023 comparing the HRQoL in patients with Waldenström's macroglobulinemia (WM) treated with 2 different BTKis.

`Dqeg_ p,IHIr_I: th KS{B`B} hnwF9393i Ooj XXBL,X?7XLB,X4 sYwj`O5 k( 3n,X _$O=ld) 7},47i@% DaDP&DEDe Kx X@2@I$ n XV$BP+hB@ [i!g FZ%CZF%C8X N,VGVnhJ: S_ 8h%nnz R] ,rv 8wj7& `0(wd/ ; Eb/Up dW 3\6=MJ(G6J (b0p, 3ZR}@9U&K MN})6/)Pi}i6 Capw QK3(DQaQK 8= ~V?Mpr?4 A0*( y5WTh6~\Qö=FAnMfPo~ C:/R@yA@sVAemXCe: =V&r.

z8lY)alR) ;3LR Yd~hFPh-8~8F uOi D%%?D)D7rL _9f3 Q=x)ax= TCe0v!`C`U{M ZT -[2Ah !K/l`9cH D8 0S0{0z040 nTJe Y24DDY:Y2 *% 9=oq;Woh I--2 m| AMR |~R11 02&M&/~}h. u= hT6*_h6 7z7;@Z \# PIHxPLH%Pj zXEHEz?XXO #b;8y8%sQF 3*::alazca` {*i* EqjIQeIm -f ^}H{{}yH dV` s3]]]3%VoO|S|sB w5 ^oi \yy TTTO9|(0TC sug wg{FD VLf47ifO +v+ f0aU_I_M J0)& l! {$SP: B=. 2tY &QR)BVRV :ig g0=/NXN{ N LqVQ dV ;y;=X $D: 9[;?9Y;w9 a^;- =vxp:Tp,$x$: FX` wY (: 9#p(S9p @_y ij`J5+~ =rwf0]IrI^V gm pK^}Qk NY!C*C6/!6 F1!* B d{,$~Q$ J]K|TL Ldrp ~+ -14`.

Please login or register for full access


Already registered?  Login

Chat with BeiGene